Home
Latest
E-paper
Companies
Industry
Economy
Blueprint
Finance
Markets
Budget
India News
Politics
External Affairs Defence Security
World News
Opinion
Technology
Immigration
Specials
Partner Content
Sports
Cricket
Lifestyle
Entertainment
Social Viral
Health
BS Decoded
Books
Education
Newsletters
Web Stories
BS at 50
Multimedia
Sudoku
Crossword
BS Apps
Management
Premium
Indulgence
Explore Business Standard
BFSI Insight Summit
Events
About Us
BS Support
Popular Search
Sun Pharma settles patent dispute with US-based Celgene Corporation
Pharma major Sun Pharmaceutical Industries Ltd. on Tuesday said it along with one of its subsidiaries have reached an agreement with Celgene Corporation (Celgene) to resolve a patent litigation.
Natco Pharma's Canadian unit, Celgene sign pact for cancer treatment drug
Lenalidomide drug is used to treat various types of cancers by slowing or stopping the growth of aberrant cells
Celgene to acquire Impact Biomedicines for up to $7 billion
Celgene is interested in Impact Biomedicines' fedratinib that has shown promise as a potential treatment for a type of blood cancer
